Sign in to view content

Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

Andrew J. Barkmeier, MD

Video
Published 2024

Related

Diabetic Retinopathy Progression in the Absence of Therapy: An Analysis of Untreated Fellow Eyes in RIDE and RISE
Sophie Jane Bakri, MD
Annual Meeting Talks
2019
Diabetic Retinopathy Lesion Types and Distribution on Ultra-Widefield Imaging and the Risk for Disease Worsening Over Time
Paolo Antonio S. Silva, MD
Annual Meeting Talks
2024
Impact of Race on Vision Outcomes in Ranibizumab-Treated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trials
M. Ali Khan, MD, FACS, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more